# Pivotal Study of the SUpira System in Patients Undergoing High-Risk Percutaneous COronaRy InTervention (HRPCI)

Study · id `cardio:ct-nct07296744` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT07296744](<https://clinicaltrials.gov/study/NCT07296744>), retrieved 18 November 2026. No person wrote or checked this page.

Also called: NCT07296744

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 358 participants.

## Technical summary

Registry record NCT07296744. Randomized; no masking; primary purpose treatment. Start 2026-05-11 (actual); primary completion 2027-11 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 358 participants (planned count; ClinicalTrials.gov record NCT07296744, source copy `cardio:ctgov-nct07296744-2026-11-18`, retrieved 2026-11-18)
- Started: 2026-05-11 (actual) (ClinicalTrials.gov record NCT07296744, source copy `cardio:ctgov-nct07296744-2026-11-18`, retrieved 2026-11-18)
- Primary completion: 2027-11 (anticipated) (ClinicalTrials.gov record NCT07296744, source copy `cardio:ctgov-nct07296744-2026-11-18`, retrieved 2026-11-18)
- Completion: 2027-11 (anticipated) (ClinicalTrials.gov record NCT07296744, source copy `cardio:ctgov-nct07296744-2026-11-18`, retrieved 2026-11-18)
- Countries: United States (ClinicalTrials.gov record NCT07296744, source copy `cardio:ctgov-nct07296744-2026-11-18`, retrieved 2026-11-18)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct07296744-2026-11-18`, retrieved 2026-11-18)

## The registry's words

- Brief title: Pivotal Study of the SUpira System in Patients Undergoing High-Risk Percutaneous COronaRy InTervention (HRPCI)
- Acronym: SUPPORT II
- Condition: Coronary Artery Disease
- Condition: High Risk Percutaneous Coronary Intervention
- Condition: Interventional Cardiology
- Condition: Mechanical Circulatory Support
- Intervention (Device): The Supira System
- Intervention (Device): Impella
- Lead sponsor: Supira Medical
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Coronary artery disease (`cardio:coronary-artery-disease`)

## Provenance

Content hash: 4334b738c3047f02fcd4b1dd2d46c06f564ef6bffa42445c8b8c98e0ffb11be0
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
